Immunotherapeutic approaches in ovarian cancer

H Yoon, A Kim, H Jang - Current Issues in Molecular Biology, 2023 - mdpi.com
Ovarian cancer (OC) is gynecological cancer, and diagnosis and treatment are continuously
advancing. Next-generation sequencing (NGS)-based diagnoses have emerged as novel …

Landscape of somatic mutated genes and inherited susceptibility genes in gynecological cancer

T Watanabe, S Soeda, C Okoshi… - Journal of Obstetrics …, 2023 - Wiley Online Library
Traditionally, gynecological cancers have been classified based on histology. Since
remarkable advancements in next‐generation sequencing technology have enabled the …

Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients

A Farolfi, E Petracci, G Gurioli, G Tedaldi… - Frontiers in …, 2023 - frontiersin.org
Introduction Primary debulking surgery (PDS), interval debulking surgery (IDS), and
platinum-based chemotherapy are the current standard treatments for advanced ovarian …

Next generation sequencing analysis of BRCA1/2 genes reveals clinically significant pathogenic mutations in ovarian cancer patients.

Y Gao, S Su, R Naz, X Yao - European Journal of …, 2024 - search.ebscohost.com
Ovarian cancer is a formidable global health concern, necessitating extensive research to
unravel its underlying genetic and epigenetic complexities. This study focuses on dissecting …

[PDF][PDF] Agnostic application of a Multigene Panel Testing including tumor susceptibility genes in Breast, Ovarian, Pancreatic and Prostate cancer patients

A Fiorino - 2023 - iris.unipa.it
Background: The pathogenic/likely pathogenic variants (PV/LPVs) into the high susceptibility
BRCA1 and BRCA2 genes have been identified as conferring predisposition to the …